https://orcid.org/0000-0003-1869-9721
References
- Nguyen JL, Yang W, Ito K, et al. Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiol. 2016;1(3):274–281.
- Macias AE, McElhaney JE, Chaves SS, et al. The disease burden of influenza beyond respiratory illness. Vaccine. 2021;39:A6–14.
- Centers for Disease Control and Prevention. People at higher risk for flu complications; [cited 2021 May 18]. Available from: https://www.cdc.gov/flu/highrisk/index.htm.
- Kwong JC, Schwartz KL, Campitelli MA, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018;378(4):345–353.
- Chow EJ, Rolfes MA, O’Halloran A, et al. Acute cardiovascular events associated with influenza in hospitalized adults: a cross-sectional study. Ann Intern Med. 2020;173(8):605–613.
- Chen L, Hao G. The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease. Cardiovasc Res. 2020;116(12):1932–1936.
- MacIntyre CR, Mahimbo A, Moa AM, et al. Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart. 2016;102(24):1953–1956.
- Khan MS, Shahid I, Anker SD, et al. Cardiovascular implications of COVID-19 versus influenza infection: a review. BMC Med. 2020;18(1):1–3.
- Clar C, Oseni Z, Flowers N, et al. Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev. 2015;2015(5):CD005050.
- Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2019;68(6):e1–e47.
- Wallick C, Wu N, To TM, et al. Antiviral use is associated with a decrease in the rate of influenza-related complications, health care resource utilization, and costs. J Med Econ. 2021;24(1):386–393.
- Muscente F, De Caterina R. Causal relationship between influenza infection and risk of acute myocardial infarction: pathophysiological hypothesis and clinical implications. Eur Heart J Suppl. 2020;22(Suppl E):E68–72.
- Boehme AK, Luna J, Kulick ER, et al. Influenza‐like illness as a trigger for ischemic stroke. Ann Clin Transl Neurol. 2018;5(4):456–463.
- Kulick ER, Alvord T, Canning M, et al. Risk of stroke and myocardial infarction after influenza-like illness in New York State. BMC Public Health. 2021;21(1):1–8.
- Barnes M, Heywood AE, Mahimbo A, et al. Acute myocardial infarction and influenza: a meta-analysis of case–control studies. Heart. 2015;101(21):1738–1747.
- Madjid M, Curkendall S, Blumentals WA. The influence of oseltamivir treatment on the risk of stroke after influenza infection. Cardiology. 2009;113(2):98–107.
- Casscells SW, Granger E, Kress AM, et al. Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases. Cardiovascul Qual Outcomes. 2009;2(2):108–115.